中国飞鹤(06186.HK)续涨6.5%重越50天线 下周一起获纳MSCI中国指数组合
中国飞鹤(06186.HK)下周一(6月1日)起正式获纳入MSCI中国指数组合,该股继昨天续跌至12.58元守稳百天线倒升3%後,今天重越10天及50天线(13.56元及13.78元),最高见14.1元,暂受制20天线(14.5元)及摩通本月升价至15元,现造14元,续升6.5%,成交已有3,806万股,涉资5.25亿元。
飞鹤是内地最大兼广为人所知的品牌婴幼儿配方奶粉生产商。股份去年11月以每股7.5元来港上市净筹65.64亿元。该公司3月下旬公布,去年纯利按年升75.5%至39.35亿元人民币,每股盈利48分人民币,末期股息19.43港仙(6月24日除净)。期内,营业额按年升32%至137.22亿人民币。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.